Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 01 - 04 tags : Therapy save search
European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) as Adjuvant Treatment for Resected Esophageal or Gastroesophageal Junction Cancer Following Chemoradiotherapy
Published: 2021-01-04 (Crawled : 15:00) - biospace.com/
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: -0.47%
H: 0.66%
C: -0.58%
cancer therapy treatment application nivolumab
European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Combined with Chemotherapy as First-Line Treatment in Metastatic Gastric Cancer, Gastroesophageal Junction Cancer and Esophageal Adenocarcinoma
Published: 2021-01-04 (Crawled : 15:00) - biospace.com/
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: -0.47%
H: 0.66%
C: -0.58%
cancer therapy treatment application nivolumab
Taysha Gene Therapies Announces Collaboration with AllStripes on SURF1-Associated Leigh Syndrome Clinical Development and Natural History
Published: 2021-01-04 (Crawled : 15:00) - biospace.com/
TSHA | $2.355 -6.92% -7.43% 790K
|
Health Technology
|
| O: 0.75%
H: 3.11%
C: -2.13%
collaboration gene therapies announces collaboration therapy gene therapy syndros
Sio Gene Therapies to Sell Arvelle Stake as Part of Angelini Pharma’s Acquisition of Arvelle Therapeutics
Published: 2021-01-04 (Crawled : 13:03) - globenewswire.com
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 2.52%
H: 10.7%
C: 9.47%
acquisition gene therapies therapy gene therapy pharma
Oncorus to Build GMP Viral Immunotherapy Clinical Manufacturing Facility in Andover, Mass.
Published: 2021-01-04 (Crawled : 12:03) - globenewswire.com
ONCR | $0.126 -75.95% 140K
|
Health Technology
|
| O: 0.62%
H: 4.4%
C: 1.75%
immunotherapy therapy
Passage Bio Receives FDA Clearance of IND Application for Lead Gene Therapy Candidate PBGM01 for Treatment of Infantile GM1 Gangliosidosis
Published: 2021-01-04 (Crawled : 12:03) - globenewswire.com
PASG | News | $1.27 3.25% 3.15% 39K
|
Health Technology
|
| O: 2.35%
H: 11.2%
C: 7.45%
gene therapy fda clearance fda therapy treatment gene therapies application clearance
Generation Bio Announces Two Non-Viral Gene Therapy Milestone Achievements: Target Levels of Factor VIII Expression in Hemophilia A Mice and Translation of Expression from Mice to Non-Human Primates
Published: 2021-01-04 (Crawled : 11:46) - globenewswire.com
GBIO | News | $2.995 -8.13% -8.85% 110K
|
Health Technology
|
| O: 1.41%
H: 6.78%
C: 4.63%
gene therapy therapy gene therapies milestone
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.